Krug, J.; Bochenek, M.L.; Gogiraju, R.; Laubert-Reh, D.; Lackner, K.J.; Münzel, T.; Wild, P.S.; Espinola-Klein, C.; Schäfer, K.
Circulating Soluble EPCR Levels Are Reduced in Patients with Ischemic Peripheral Artery Disease and Associated with Markers of Endothelial and Vascular Function. Biomedicines 2023, 11, 2459.
https://doi.org/10.3390/biomedicines11092459
AMA Style
Krug J, Bochenek ML, Gogiraju R, Laubert-Reh D, Lackner KJ, Münzel T, Wild PS, Espinola-Klein C, Schäfer K.
Circulating Soluble EPCR Levels Are Reduced in Patients with Ischemic Peripheral Artery Disease and Associated with Markers of Endothelial and Vascular Function. Biomedicines. 2023; 11(9):2459.
https://doi.org/10.3390/biomedicines11092459
Chicago/Turabian Style
Krug, Janina, Magdalena L. Bochenek, Rajinikanth Gogiraju, Dagmar Laubert-Reh, Karl J. Lackner, Thomas Münzel, Philipp S. Wild, Christine Espinola-Klein, and Katrin Schäfer.
2023. "Circulating Soluble EPCR Levels Are Reduced in Patients with Ischemic Peripheral Artery Disease and Associated with Markers of Endothelial and Vascular Function" Biomedicines 11, no. 9: 2459.
https://doi.org/10.3390/biomedicines11092459
APA Style
Krug, J., Bochenek, M. L., Gogiraju, R., Laubert-Reh, D., Lackner, K. J., Münzel, T., Wild, P. S., Espinola-Klein, C., & Schäfer, K.
(2023). Circulating Soluble EPCR Levels Are Reduced in Patients with Ischemic Peripheral Artery Disease and Associated with Markers of Endothelial and Vascular Function. Biomedicines, 11(9), 2459.
https://doi.org/10.3390/biomedicines11092459
